You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 27, 2024

DIPROSONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Diprosone, and what generic alternatives are available?

Diprosone is a drug marketed by Schering and is included in four NDAs.

The generic ingredient in DIPROSONE is betamethasone dipropionate. There are sixty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Diprosone

A generic version of DIPROSONE was approved as betamethasone dipropionate by FOUGERA PHARMS on June 26th, 1984.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DIPROSONE?
  • What are the global sales for DIPROSONE?
  • What is Average Wholesale Price for DIPROSONE?
Drug patent expirations by year for DIPROSONE
Recent Clinical Trials for DIPROSONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
LEO PharmaPhase 1
Centre Oscar LambretPhase 2
Roche Pharma AGPhase 2

See all DIPROSONE clinical trials

US Patents and Regulatory Information for DIPROSONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering DIPROSONE betamethasone dipropionate CREAM;TOPICAL 017536-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Schering DIPROSONE betamethasone dipropionate OINTMENT;TOPICAL 017691-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Schering DIPROSONE betamethasone dipropionate DISC;TOPICAL 017829-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Schering DIPROSONE betamethasone dipropionate LOTION;TOPICAL 017781-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.